BRPI0601330A - composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais - Google Patents

composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais

Info

Publication number
BRPI0601330A
BRPI0601330A BRPI0601330-9A BRPI0601330A BRPI0601330A BR PI0601330 A BRPI0601330 A BR PI0601330A BR PI0601330 A BRPI0601330 A BR PI0601330A BR PI0601330 A BRPI0601330 A BR PI0601330A
Authority
BR
Brazil
Prior art keywords
biocellulose
cream
treatment
aqueous suspension
aerosol
Prior art date
Application number
BRPI0601330-9A
Other languages
English (en)
Inventor
Silvio Jose De Souza
Original Assignee
Wellborn Participacoes Societa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellborn Participacoes Societa filed Critical Wellborn Participacoes Societa
Priority to BRPI0601330-9A priority Critical patent/BRPI0601330A/pt
Priority to US11/593,309 priority patent/US20070231271A1/en
Publication of BRPI0601330A publication Critical patent/BRPI0601330A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSIçãO TóPICA DE BIOCELULOSE EM FORMA DE GEL, SPRAY- AEROSOL, CREME E OU SUSPENSãO AQUOSA PARA TRATAMENTO DE LESõES EPITELIAIS, refere-se a uma nova forma farmacêutica de utilização da celulose bacteriana também conhecida como biocelulose e consiste em um prático e efetivo curativo de fácil aplicação, mais particularmente em uma composição em forma de gel, creme, spray-aerosol, ou suspensão aquosa para uso na área médica como curativo nas lesões de pele, e apresenta a vantagem de formar uma barreira protetora no ferimento e oferecer uma quantidade maior de agente ativo ao ferimento, pelo fato de estar associado a outras substâncias que contêm propriedades farmacêuticas e permite uma aplicação fácil e homogênea e confere conforto ao paciente quando aplicado.
BRPI0601330-9A 2006-03-31 2006-03-31 composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais BRPI0601330A (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0601330-9A BRPI0601330A (pt) 2006-03-31 2006-03-31 composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais
US11/593,309 US20070231271A1 (en) 2006-03-31 2006-11-06 Topical composition of biocellulose as gel, spray-aerosol, cream and/or aqueous for the treatment of epithelial lesions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0601330-9A BRPI0601330A (pt) 2006-03-31 2006-03-31 composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais

Publications (1)

Publication Number Publication Date
BRPI0601330A true BRPI0601330A (pt) 2007-12-04

Family

ID=38559257

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0601330-9A BRPI0601330A (pt) 2006-03-31 2006-03-31 composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais

Country Status (2)

Country Link
US (1) US20070231271A1 (pt)
BR (1) BRPI0601330A (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776807B2 (en) * 2008-07-11 2010-08-17 Conopco, Inc. Liquid cleansing compositions comprising microfibrous cellulose suspending polymers
FR2936714B1 (fr) * 2008-10-02 2016-06-24 Oreal Procede de traitement cosmetique et ensemble pour la mise en oeuvre d'un tel procede
WO2010065908A2 (en) * 2008-12-05 2010-06-10 Catchmark Jeffrey M Degradable biomolecule compositions
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
CN101869516B (zh) * 2010-06-07 2011-10-26 钟春燕 一种细菌纤维素冰敷袋及其生产方法
CN102415997B (zh) * 2011-12-09 2014-06-18 海南光宇生物科技有限公司 一种生物纤维素气雾剂
KR101371379B1 (ko) * 2012-01-26 2014-03-07 (주) 유쎌 건조 바이오 셀룰로오스의 제조 방법
FI126109B (en) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibril polysaccharide for use in the control and prevention of constriction and scarring
US10202517B2 (en) 2013-07-26 2019-02-12 The Penn State Research Foundation Polymer compositions and coatings
TWI586373B (zh) * 2014-02-06 2017-06-11 奈菲兒生醫股份有限公司 含有生物纖維膜碎片之化妝品組成物及其製造方法
US11648197B2 (en) 2018-06-28 2023-05-16 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
WO2020031186A1 (en) * 2018-08-06 2020-02-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cellulose-based topical formulations
KR102141963B1 (ko) * 2018-10-04 2020-08-06 주식회사 엘지생활건강 피부용 베이스 화장료 조성물
JP7396641B2 (ja) * 2019-11-18 2023-12-12 日本メナード化粧品株式会社 二剤同時吐出型泡沫形成エアゾール製品
CN111939314A (zh) * 2020-07-28 2020-11-17 天津科技大学 一种用于伤口创面的细菌纤维素软膏的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588400A (en) * 1982-12-16 1986-05-13 Johnson & Johnson Products, Inc. Liquid loaded pad for medical applications
US4655758A (en) * 1982-12-16 1987-04-07 Johnson & Johnson Products, Inc. Microbial polysaccharide articles and methods of production
BR8404937A (pt) * 1984-10-01 1986-05-06 Bio Fill Ind E Comercio De Pro Processo para preparacao de pelicula de celulose,pelicula de celulose obtida pelo mesmo,implante de pele artificial,processo de tratamento de lesoes empregando a referida pelicula de celulose e utilizacao
US20030013163A1 (en) * 2000-02-17 2003-01-16 Dieter Klemm Method and device for producing shaped microbial cellulose for use as a biomaterial, especially for microsurgery
US20040019092A1 (en) * 2001-11-14 2004-01-29 Daniel Berney Non-peptide somatostatin receptor ligands
US20050019380A1 (en) * 2002-04-26 2005-01-27 Xylos Corporation Microbial cellulose wound dressing for treating chronic wounds
US20040142019A1 (en) * 2003-01-16 2004-07-22 Xylos Corporation Microbial-derived cellulose amorphous hydrogel wound dressing

Also Published As

Publication number Publication date
US20070231271A1 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
Rezvani Ghomi et al. The evolution of wound dressings: From traditional to smart dressings
BRPI0601330A (pt) composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais
Pereira et al. Influence of Aloe vera on water absorption and enzymatic in vitro degradation of alginate hydrogel films
ES2334667T3 (es) Materiales con tratamiento antimicrobiano.
US9044488B2 (en) Medicinal cream made using silver sulphadiazine and chitosan and a process to make it
CA2797707C (en) System and method for alleviating the appearance of scars and/or scar tissue
BRPI0925036B8 (pt) uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele
Tricou et al. Wound pH-modulating strategies for diabetic wound healing
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
BR112013025493A2 (pt) composição aquosa administrável de maneira tópica a um olho humano ou animal, método para tratar uma afecção que envolve deficiências em lágrimas naturais no olho humano ou animal, composição para aplicação tópica no tratamento de um distúrbio ou afecção ocular do olho humano ou animal, método para tratar um distúrbio ou afecção ocular do olho humano ou animal, composição para uso no tratamento de dor associada ao olho humano ou animal e método para alívio da dor no olho humano ou animal ou próximo ao mesmo
BRPI0907086A2 (pt) Composição para uso na redução da aparência de linhas finas ou rugas ou para a redução da inflamação da pele com ingredientes ativos aromáticos e uso de 4-etil-3,7-dimetilocta -1,6-dien-3-ol ou 2-isobutil-4-metiltetra-hidro-2h-piran-4-ol para a preparação de uma composição para o tratamento ou prevenção de uma condição da pele
WO2010079209A3 (en) Compositions for treating wounds and skin conditions
Gil et al. A PEGylated fibrin hydrogel‐based antimicrobial wound dressing controls infection without impeding wound healing
CN105012993A (zh) 一种阳离子医用生物胶抗菌敷料及其制备方法
BR112022015727A2 (pt) Métodos para a preparação de uma quitosana reticulada, para a preparação de um sistema de liberação de fármacos, para prevenir, tratar ou melhorar um distúrbio médico e para identificar uma quitosana reticulada, quitosana reticulada, composição, enchimento de tecido mole, curativo para ferimentos ou tecido de reconstrução, nanopartículas, meio de cultura para células ou tecido biológico, uso de quitosana reticulada, e, kit
WO2010063030A3 (en) Dermal application of vasoconstrictors
CN104399111A (zh) 一种三聚氰胺交联聚乙烯醇水凝胶敷料、制备方法及其应用
JP6092781B2 (ja) 抗菌および創傷治癒活性を持つ組成物
Antosik et al. Polysaccharide films modified by compounds of natural origin and silver having potential medical applications
Vanić et al. Hydrogels as intrinsic antimicrobials
SI2874614T1 (en) Water-soluble film which has a healing effect
US9579388B2 (en) System and method for alleviating the appearance of scars and/or scar tissue
AU2015268649B2 (en) A composition and method of applying same & a composition that assists healing burns and wounds with antibacterial and anti-fungal actions
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
RU2603459C1 (ru) Ранозаживляющий гель для наружного применения

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: WELLBORN PARTICIPACOES SOCIETARIAS LTDA. (BR/PR)

B25G Requested change of headquarter approved

Owner name: WELLBORN PARTICIPACOES SOCIETARIAS LTDA. (BR/PR)

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]